Postdoctoral fellow in Sensory Neuroscience
Do you want to contribute to improving human health?In our research group, you will find a unique opportunity to work together with top researchers in the intersection between psychology and…
Do you want to contribute to improving human health?In our research group, you will find a unique opportunity to work together with top researchers in the intersection between psychology and…
This advertisement has not loaded yet, but your article continues below. Two doses of the Pfizer Inc and BioNTech COVID-19 vaccine are highly protective against a rare but often serious condition in…
ReportsnReports publishes the report titled Preimplantation Genetic Screening that presents a 360-degree overview of the market under one roof. The report is developed with the meticulous efforts of an enthusiastic and experienced team of experts, analyts, and researchers that makes
Scientific Reports – Workplace neighbourhood built-environment…
The research reports on ‘Advanced & Targeted Drug Delivery Market’ report gives detailed overview of factors that affect global business scope. Advanced & Targeted Drug Delivery Market report shows the latest market insights with upcoming trends and breakdowns of products
A Foresite-incubated biotech that debuted just eight months ago closed a new mega financing round on Thursday, and with it comes a company rebranding. Esker Therapeutics will now call itself Alumis…
Bursting at the seams and executing plans for swift expansion to support its manufacturing work for the mRNA vaccine out of Pfizer/BioNTech, Indianapolis-based Exelead has now been scooped up in a…
Around the same time serial entrepreneur Gary Glick was putting together his latest (and biggest yet) venture, Odyssey Therapeutics this past March, a mentee introduced him to a young London-based…
A spinout from an MIT lab has landed a deal with a Swedish development group to build a $125 million manufacturing facility in Woburn, MA, just 15 miles outside Boston. Skanska signed a contract with…
On his way out of Alnylam, outgoing CEO John Maraganore, who had led the biotech through thick and thin for 19 years, said late last year he wanted to advise new biotech companies in the grandfather…